TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Judy Matthews
Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025

Iterum Therapeutics will release its third quarter 2025 financial results on November 14, 2025, with a conference call to discuss results and provide a business update. The company has received FDA approval for ORLYNVAH, an oral antibiotic for treating urinary tract infections.

Insights
DE   neutral

Mentioned as part of newly elected Board of Directors without specific context


ITRM   positive

Company received FDA approval for ORLYNVAH, has Fast Track and QIDP designations, and is hosting a financial results conference call, indicating ongoing business development and progress